Skip to main content

Table 1 Characteristics of patients whose thymus were used for RT-PCR experiments

From: Decreased expression of miR-29 family associated with autoimmune myasthenia gravis

Patient ID

Gender

Age (years)

Degree of thymic hyperplasia (1)

Interval

onset - thymectomy (months)

MGFA score at thymectomy (2)

Corticoid treatment

Cholinesterase inhibitors

Anti-AChR titer (nmol/L)

MG1

F

15

Low

13

III b

No

Yes

3.45

MG2

F

23

Low

7

II a

No

Yes

2118.7

MG3

F

29

Low

7

I a

No

NS

83.7

MG4

F

35

Low

24

IV a

No

Yes

11.1

MG5

F

20

Low

6

II a

No

Yes

> 100

MG6

F

32

Low

6

II b

No

Yes

17.3

MG7

F

30

High

2

IV a

No

NS

> 100

MG8

F

30

High

14

I

No

NS

3180.2

MG9

F

25

High

3

II a

No

Yes

3.21

MG10

F

28

High

4

II a

No

Yes

60.38

MG11

F

28

High

36

III a

No

Yes

9.7

MG12

F

22

High

2

III a

No

Yes

264

  1. (1) Degree of thymic hyperplasia: low hyperplasia (with 2 or fewer GCs per section) or high hyperplasia (with 3 or more GCs per section). (2) Clinical classification according to the Myasthenia Gravis Foundation of America (MGFA)